Altamira Therapeutics Ltd is a biopharmaceutical company focused on developing innovative therapies for neurological and other serious conditions
The company leverages its proprietary technology platforms to create treatments that enhance drug delivery and optimize patient outcomes. With a commitment to addressing unmet medical needs, Altamira is engaged in advancing its product candidates through various stages of preclinical and clinical development, aiming to provide new therapeutic options for patients who suffer from debilitating diseases.
On Thursday, I saw that some penny stocks were already trading over 100 million shares, with others around 30 million. It was clear: penny stocks were in focus. Here’s how the trades went down.
Altamira Therapeutics shares are trading higher Thursday after the company announced highlights from its NASAR clinical trial with Bentrio nasal spray were published in video format on the social media channels of the allergology journal, "Allergy."
Companies Reporting Before The Bell • Delta Air Lines (NYSEDAL) is projected to report quarterly earnings at $0.35 per share on revenue of $12.55 billion.
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Monday. The Dow traded down 0.37% to 39,331.42 while the NASDAQ rose 0.06% to 16,439.38. The S&P 500 also fell, dropping, 0.12% to 5,227.95.
U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 100 points on Monday. The Dow traded down 0.22% to 39,389.17 while the NASDAQ fell 0.15% to 16,410.10. The S&P 500 also fell, dropping, 0.16% to 5,226.01.
Altamira Therapeutics shares are trading higher Monday after the company announced that it has entered into a collaboration agreement with Univercells Group to evaluate the use of the company's proprietary SemaPhore platform for the delivery of mRNA vaccines. Under the terms of the agreement, Univercells will test a proprietary mRNA vaccine delivered with Altamira's SemaPhore nanoparticle platform. If the experiments are successful, the companies intend to discuss and negotiate a commercial agreement for the development and manufacturing of nanoparticle-based mRNA vaccines using Univercells' production platform.
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 50 points on Monday. Following the market opening Monday, the Dow traded down 0.16% to 39,412.36 while the NASDAQ fell 0.42% to 16,359.31. The S&P 500 also fell, dropping, 0.23% to 5,222.33.
Shares of bluebird bio, Inc. (NASDAQBLUE) rose sharply during Monday’s session after the company presented updated data from its gene therapy program in transfusion-dependent beta-thalassemia at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition.
Altamira Therapeutics Ltd (NASDAQCYTO) shares are trading lower by 50% to $0.20 Monday morning after the company recently made strategic moves by partially spinning off its Bentrio business to focus on
U.S. stocks traded mixed this morning, with the Dow Jones index gaining more than 20 points on Monday. Following the market opening Monday, the Dow traded up 0.07% to 36,272.54 while the NASDAQ fell 0.26% to 14,366.24. The S&P 500 also fell, dropping, 0.02% to 4,603.60.
